Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Framework vs Ryze Rx

Framework
Graded #230

Higher grade

vs+6.8999999999999915
Ryze Rx
Graded #376

Lower grade

The verdict

Framework takes it — 65.1/100 to 58.2/100.

Framework grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Framework is a personalized-plan GLP-1 telehealth platform offering compounded semaglutide and tirzepatide with doctor-guided treatment selection.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFramework +36
80
44
Dose & formulationEven
64
64
Clinical oversightRyze Rx +3
72
75
Labs & monitoringEven
52
52
FulfillmentRyze Rx +12
57
69
Contract termsEven
41
41
Framework · left barRyze Rx · right bar

The numbers

MetricFrameworkRyze Rx
WeighScore65.1/10058.2/100
GradeCC
Scorecard rank#230#376
Semaglutide$100/mo (starting dose, compounded)$199/mo (starting dose, 3 month plan, compounded)
Tirzepatide$100/mo (starting dose, compounded)$199/mo (starting dose, 3 month plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Framework

Graded #230 · C

Strengths

  • Named 503B pharmacy partner (The Pharmacy Hub) disclosed — the FDA-registered outsourcing-facility pathway, distinct from 503A
  • Publishes the FDA compounded-medication disclaimer
  • $25/week pricing (~$100/mo) is among the most aggressive in the directory
  • $0 membership fees
  • Phone support published, toll-free (888) 412-0666

Where it loses points

  • LegitScript ID / certification not shown on the homepage
  • States-served list not disclosed
  • Medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed (no footer copyright)
  • Governing law / arbitration venue not stated
Ryze Rx

Graded #376 · C

Strengths

  • Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
  • Physician consultation, ongoing clinical support and discreet shipping included with each prescription
  • Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
  • Free shipping, 24hr prescription turnaround, FSA/HSA eligible; care advertised in all 50 states

Where it loses points

  • Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
  • Pharmacy partners not named - only 'US-licensed compounding pharmacies'
  • Homepage advertises GLP-1s 'from $149/mo' but the catalog lists $199/mo
  • On-site '4.9/5, 2,400+ reviews' is self-reported, not an independently verified rating

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard